Advancing Cancer Research in Norway: Eli Lilly’s SUNRAY-01 Study
Eli Lilly selected Norway as the site for its groundbreaking study project, despite the decline of the recent year’s number of clinical cancer trials.
Unique collaboration to build Nordic health industry
A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
A peak into Cancer Crosslinks
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.
Making Cancer Crosslinks possible
Meet the sponsors behind Cancer Crosslinks 2024: Bristol Myers Squibb and Daiichi-Sankyo.
Meet our new members
Meet the members who recently joined or re-joined our cluster.
Cancer Crosslinks 2024: meet the speakers
Join us for a day of educational talks and mingling with colleagues in the oncology community.